Concepedia

Takeshi Kadokura

TK

Statistics

Publications

15

Citations

562

H-Index

13

Active since

2008

Affiliations

Astellas Pharma (Japan)(Current)

Astellas Pharma (Netherlands)

Astellas Pharma (United States)

Center for Global Development

Jikei University School of Medicine

Takeshi Kadokura is an author at Astellas Pharma (Japan) specializing in pharmacology, clinical pharmacology, and pharmacy.

Publications per year

2008–2024

15

Publications

15

Renal Glucose Handling

Ele Ferrannini, Stephan A. Veltkamp, Ronald Smulders et al. · Diabetes Care · 2013 · 81 citations · Full text

, , +17

A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma

Shunji Takahashi, Motohide Uemura, Tomokazu Kimura et al. · Investigational New Drugs · 2019 · 79 citations · Full text

, , +14

Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor

Angela James, Catherine C. Smith, Mark R. Litzow et al. · Clinical Pharmacokinetics · 2020 · 72 citations · Full text

, , +13

Effect of Ipragliflozin (ASP1941), a Novel Selective Sodium-Dependent Glucose Co-Transporter 2 Inhibitor, on Urinary Glucose Excretion in Healthy Subjects

Stephan A. Veltkamp, Takeshi Kadokura, Walter Krauwinkel et al. · Clinical Drug Investigation · 2011 · 55 citations

, , +13

Clinical Pharmacology of the Antibody–Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors

Mei Tang, Amit Garg, Peter L. Bonate et al. · Clinical Pharmacokinetics · 2024 · 39 citations · Full text

, , +16

1–5 of 15